Federal Register
Notices
> Manufacturers 2008 >
Sigma Aldrich Research Biochemicals, Inc.
FR Doc E8-18065[Federal Register: August 6, 2008 (Volume 73, Number 152)]
[Notices] [Page 45783-45784] From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr06au08-90]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated March 19, 2008 and published in the Federal Register on March
28, 2008, (73 FR 16719), Sigma Aldrich Research Biochemicals, Inc., 4-3
Strathmore Road, Natick, Massachusetts 01760- 2447, made application by renewal
to the Drug Enforcement Administration (DEA) to be registered as a bulk
manufacturer of the basic classes of controlled substances listed in schedules I
and II:
Drug
|
Schedule
|
Cathinone (1235)
|
I
|
Methcathinone (1237)
|
I
|
Aminorex (1585)
|
I
|
Alpha-ethyltryptamine (7249)
|
I
|
Lysergic acid diethylamide (7315)
|
I
|
Tetrahydrocannabinols (7370)
|
I
|
4-Bromo-2,5-dimethoxyamphetamine (7391)
|
I
|
4-Bromo-2,5-dimethoxyphenethylamine (7392)
|
I
|
2,5-Dimethoxyamphetamine (7396)
|
I
|
3,4-Methylenedioxyamphetamine (7400)
|
I
|
N-Hydroxy-3,4-methylenedioxy- amphetamine (7402)
|
I
|
3,4-Methylenedioxy-N-ethylamphetamine (7404)
|
I
|
3,4-Methylenedioxymethamphet- amine (MDMA) (7405)
|
I
|
1-[1-(2-Thienyl)cyclohexyl]piper- idine (TCP) (7470)
|
I
|
1-Benzylpiperazine (BZP) (7493)
|
I
|
Heroin (9200)
|
I
|
Normorphine (9313)
|
I
|
Amphetamine (1100)
|
II
|
Methamphetamine (1105)
|
II
|
Nabilone (7379)
|
II
|
1-Phenylcyclohexylamine (7460)
|
II
|
Phencyclidine (7471)
|
II
|
Cocaine (9041)
|
II
|
Codeine (9050)
|
II
|
Diprenorphine (9058)
|
II
|
Ecgonine (9180)
|
II
|
Levomethorphan (9210)
|
II
|
Levorphanol (9220)
|
II
|
Meperidine (9230)
|
II
|
Metazocine (9240)
|
II
|
Methadone (9250)
|
II
|
Morphine (9300)
|
II
|
Thebaine (9333)
|
II
|
Levo-alphacetylmethadol (9648)
|
II
|
Carfentanil (9743)
|
II
|
Fentanyl (9801)
|
II
|
The company plans to manufacture reference standards.
No comments or objections have been received. DEA has considered the factors
in 21 U.S.C. 823(a) and determined that the registration of Sigma Aldrich
Research Biochemicals, Inc. to manufacture the listed basic classes of
controlled substances is consistent with the public interest at this time. DEA
has investigated Sigma Aldrich Research Biochemicals, Inc. to ensure that the
company's registration is consistent with the public interest. The investigation
has included inspection and testing of the company's physical
[[Page 45784]]
security systems, verification of the company's compliance with state and
local laws, and a review of the company's background and history. Therefore,
pursuant to 21
U.S.C. 823, and in accordance with 21 CFR
1301.33, the above
named company is granted registration as a bulk manufacturer of the basic
classes of controlled substances listed.
Dated: July 30, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion
Control, Drug Enforcement Administration.
[FR Doc. E8-18065 Filed 8-5-08; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
|